Markman Biologics Patents – Insights & Stats (Updated 2023)

Markman Biologics has a total of 12 patents globally, out of which 6 have been granted. Of these 12 patents, more than 83% patents are active. The United States of America is where Markman Biologics has filed the maximum number of patents, followed by Australia and Europe (EPO). Parallelly, the United States of America seems to be the main focused R&D centre and also is the origin country of Markman Biologics.

Markman Biologics was founded in 2017. Biotechnology startup Markman Biologics has secured several innovative patents related to micro-resurfacing of Internal and External Medical Reconstructive Tissue Grafts.

Do read about some of the most popular patents of Markman Biologics which have been covered by us in this article and also you can find Markman Biologics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Markman Biologics patent portfolio.

How many patents does Markman Biologics have?

Markman Biologics has a total of 12 patents globally. These patents belong to 1 unique patent family. Out of 12 patents, 10 patents are active.

How Many Patents did Markman Biologics File Every Year?

Markman Biologics Patents Filing Trend
Year of Patents Filing or GrantMarkman Biologics Applications FiledMarkman Biologics Patents Granted
20231
20221
20214
20201
201931
201711
201511
20141
20121
20111

How many Markman Biologics patents are Alive/Dead?

Worldwide Patents

Markman Biologics Patents Portfolio

How Many Patents did Markman Biologics File in Different Countries?

Markman Biologics Worldwide Patents

Countries in which Markman Biologics Filed Patents

CountryPatents
United States Of America8
Australia1
Europe1

Where are Research Centers of Markman Biologics Patents Located?

The United States of America is where Markman Biologics performed R&D.

Best Markman Biologics Patents

US8858647B2 is the most popular patent in the Markman Biologics portfolio. It has received 25 citations so far from companies like Lifecell Corporation.

What Percentage of Markman Biologics US Patent Applications Were Granted?

Markman Biologics (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 5 have been granted leading to a grant rate of 100%.

Below are the key stats of Markman Biologics’ patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Markman Biologics?

Law FirmTotal ApplicationsSuccess Rate
Weide & Miller Ltd4100.0%
Henry Patent Law Firm Pllc30%

List of Markman Biologics patents:-

Markman Biologics PatentsTitle
US11701213B2Method And Apparatus For Creating A Modified Tissue Graft
US11246697B2Method And Apparatus For Creating A Reconstructive Graft
US10285795B2Method And Apparatus For Creating A Reconstructive Graft
US9622845B2Method And Apparatus For Creating A Reconstructive Graft
US9050177B2Method And Apparatus For A Process Creating An Internal Tissue Graft For Animal And Human Reconstructive Purposes
US8858647B2Method And Apparatus For A Process Creating An Internal Tissue Graft For Animal And Human Reconstructive Purposes
US20210128290A1Method And Apparatus For Creating A Modified Tissue Graft
US20200222167A1Method And Apparatus For Creating A Modified Tissue Graft
EP4125711A1Modified Tissue Graft And Methods And Apparatus For Creating A Modified Tissue Graft
AU2021242217A1Modified Tissue Graft And Methods And Apparatus For Creating A Modified Tissue Graft
WO2021194817A1Modified Tissue Graft And Methods And Apparatus For Creating A Modified Tissue Graft
WO2020167347A1Method And Apparatus For Creating A Modified Tissue Graft

What are Markman Biologics key innovation segments?

What Technologies are Covered by Markman Biologics?

The chart below distributes patents filed by Markman Biologics in different countries on the basis of the technology protected in patents. It also represents the markets where Markman Biologics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Markman Biologics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Markman Biologics?

Related Articles

5ire Patents – Insights & Stats (Updated 2024)

5ire has a total of 7 patents globally, out of which no patent has been granted. Of these 7 patents, more than 14% patents are active. The United States of America and United Kingdom is where 5ire has filed the maximum number of patents, followed by Europe (EPO). Parallelly, United

Read More »

Abogen Patents – Insights & Stats (Updated 2024)

Abogen has a total of 25 patents globally, out of which 10 have been granted. Of these 25 patents, more than 48% patents are active. Japan is where Abogen has filed the maximum number of patents, followed by Europe (EPO). Parallelly, Europe (EPO) seems to be the main focused R&D

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.